CLINICAL IMMUNOLOGY
Ragweed-allergic subjects have decreased serum levels of chemokines CCL2, CCL3, CCL4 and CCL5 out of the pollen season
 
More details
Hide details
 
Submission date: 2015-07-02
 
 
Final revision date: 2015-08-18
 
 
Acceptance date: 2015-08-19
 
 
Publication date: 2016-01-15
 
 
Cent Eur J Immunol 2015;40(4):442-446
 
KEYWORDS
ABSTRACT
CC-chemokines are important mediators of the allergic responses and regulate the cell trafficking. The aim of this study was to examine the serum levels of CCL2/MCP-1, CCL3/MIP-1, CCL4/MIP-1 and CCL5/RANTES, and to determine whether there are differences between ragweed-allergic subjects and healthy individuals out of the pollen season. Peripheral blood samples were collected from 24 subjects allergic to ragweed pollen and 12 healthy controls. Serum concentrations of chemokines/cytokines were measured by an enzyme-linked immunosorbent assay. We observed significantly decreased concentrations of CCL2/MCP-1, CCL3/MIP-1, CCL4/MIP-1 and CCL5/RANTES in the sera of ragweed-allergic patients compared to the healthy individuals (32.2 vs. 106.4 pg/ml, 89.5 vs. 135.7 pg/ml, 63.4 vs. 119.2 pg/ml and 11.2 vs. 18.1 ng/ml, respectively, p < 0.01). In contrast to the CC-chemokines, the serum levels of IL-8/CXCL8 showed a significant increase (p < 0.05) in the allergic group compared to the non-allergic subjects. Interleukin 4 levels were similar in both groups. In the sera of allergic patients, we have also detected significantly elevated levels of ragweed-specific IgE and IgG. However, decreased serum concentrations of the four CC-chemokines and elevated levels of IL-8/CXCL8 can be used as biomarkers for more accurate evaluation of the allergic status of patients with pollen allergy out of the season, to study the mechanisms for activation/inhibition of the subclinical allergic responses and for development of therapeutic strategies.
REFERENCES (19)
1.
Zlotnik A, Yoshie O (2012): The chemokine superfamily revisited. Immunity 36: 705-716.
 
2.
Rollins BJ (1997): Chemokines. Blood 90: 909-928.
 
3.
Alam R, York J, Boyars M, et al. (1996): Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients. Am J Respir Crit Care Med 153: 1398-1404.
 
4.
Miotto D, Christodoulopoulos P, Olivenstein R, et al. (2001): Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases. J Allergy Clin Immunol 107: 664-670.
 
5.
Emad A, Emad V (2007): Elevated levels of MCP-1, MIP-alpha and MIP-1 beta in the bronchoalveolar lavage (BAL) fluid of patients with mustard gas-induced pulmonary fibrosis. Toxicology 240: 60-69.
 
6.
Emad A, Emad Y (2007): Relationship between eosinophilia and levels of chemokines (CCL5 and CCL11) and IL-5 in bronchoalveolar lavage fluid of patients with mustard gas-induced pulmonary fibrosis. J Clin Immunol 27: 605-612.
 
7.
Sim TC, Reece LM, Hilsmeier KA, et al. (1995): Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment. Am J Respir Crit Care Med 152: 927-933.
 
8.
Kuna P, Lazarovich M, Kaplan AP (1996): Chemokines in seasonal allergic rhinitis. J Allergy Clin Immunol 97: 104-112.
 
9.
Ghazanfari T, Yaraee R, Kariminia A, et al. (2009): Alterations in the serum levels of chemokines 20 years after sulfur mustard exposure: Sardasht-Iran Cohort Study. Int Immunopharmacol 9: 1471-1476.
 
10.
Holgate ST, Bodey KS, Janezic A, et al. (1997): Release of RANTES, MIP-1 alpha, and MCP-1 into asthmatic airways following endobronchial allergen challenge. Am J Respir Crit Care Med 156: 1377-1383.
 
11.
Radman M, Hassanshahi G, Vazirinejad R, et al. (2013): Serum levels of the CC chemokines CCL2, CCL5, and CCL11 in food allergic children with different clinical manifestations. Inflammation 36: 561-566.
 
12.
Glez PP, Franco YB, Matheu V (2012): MIP-1alpha, MCP-1, and desensitization in anaphylaxis from cow’s milk. N Engl J Med 367: 282-284.
 
13.
Alam R, Stafford S, Forsythe P, et al. (1993): RANTES is a chemotactic and activating factor for human eosinophils. J Immunol 150: 3442-3448.
 
14.
Schall TJ, Bacon K, Camp RD, et al. (1993): Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J Exp Med 177: 1821-1826.
 
15.
Borish LC, Steinke JW (2003): 2. Cytokines and chemokines. J Allergy Clin Immunol 111: S460-S475.
 
16.
Kuna P, Reddigari SR, Schall TJ, et al. (1993): Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family. J Immunol 150: 1932-1943.
 
17.
Zhang HH, Song K, Rabin RL, et al. (2010): CCR2 identifies a stable population of human effector memory CD4+ T cells equipped for rapid recall response. J Immunol 185: 6646-6663.
 
18.
Gabrielsson S, Soderlund A, Paulie S, et al. (1998): Increased frequencies of allergen-induced interleukin-13-producing cells in atopic individuals during the pollen season. Scand J Immunol 48: 429-435.
 
19.
Carlsson M, Thorell L, Sjolander A, Larsson-Faria S (2015): Variability of total and free IgE levels and IgE receptor expression in allergic subjects in and out of pollen season. Scand J Immunol 81: 240-248.
 
eISSN:1644-4124
ISSN:1426-3912
Journals System - logo
Scroll to top